LR Molecular Partners AG (SIX: MOLN; NASDAQ: MOLN), a clinical-stage biotech company developing a new class of custom-built protein drugs known as DARPin therapeutics ("Molecular Partners" or the ...

Discover how a new library enhances drug exposure records via untargeted metabolomics data, revealing hidden medication ...

KOMZIFTI (ziftomenib), the first and only once-daily oral menin inhibitor for adult patients with R/R AML with a susceptible NPM1 mutation who have no satisfactory alternative treatment options, has ...

Doctors and researchers try to understand what medications a person has taken by asking patients directly or by looking at medical records. But this information is often incomplete.

Being slight oddities, brown dwarfs occupy a strange but useful niche in astronomy. Unlike exoplanets, which are often ...

Pancreatic Cancer Market Set to Expand During the Forecast Period (2025-2034) as Precision Medicine and Immunotherapy Transform Treatment Landscape | DelveInsight ...

New data show 100% (6/6) objective response rate (ORR) with EO2463 in previously untreated patients with follicular lymphoma needing treatment in combination with rituximab (SIDNEY Cohort 3) -- Of the ...

The Deutsche Forschungsgemeinschaft (DFG, German Research Foundation) is establishing nine new Collaborative Research Centres (CRC) to further support ...

New data show 100% (6/6) objective response rate (ORR) with EO2463 in previously untreated patients with follicular lymphoma needing treatment in ...

Explore the full archive of TIME, a century of journalism, insight, and perspective, with AI that helps you research, connect ...

NASA and the European Space Agency plan to bring samples back from Mars. Could they harbor a type of life that scientists warn could trigger mass extinctions on Earth?